Luc Camoin

Aix-Marseille Univ, Institut Paoli-Calmettes, CRCM

Affiliated withInstitut Paoli-Calmettes, CRCM

Research Area

Biography

Luc Camoin has not added Biography.
If you are Luc Camoin and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2019

Other Publications

Article	Year
Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection. Virus research\| PubMed ID: 24184319	2014
Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins. Journal of proteome research\| PubMed ID: 24654937	2014
Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified. Biochemical and biophysical research communications\| PubMed ID: 25944660	2015
Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family. Journal of proteomics\| PubMed ID: 27492143	2016
The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells. The Journal of experimental medicine\| PubMed ID: 27647348	2016
How may targeted proteomics complement genomic data in breast cancer? Expert review of proteomics\| PubMed ID: 27813428	2017
Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination. PloS one\| PubMed ID: 28099510	2017
Fibronectin-guided migration of carcinoma collectives. Nature communications\| PubMed ID: 28102238	2017
EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 29162697	2017
Cyclipostins and cyclophostin analogs inhibit the antigen 85C from both and . The Journal of biological chemistry\| PubMed ID: 29301937	2018
Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer. Clinical proteomics\| PubMed ID: 29657559	2018
Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies. Journal of molecular biology\| PubMed ID: 29782831	2018
O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins. Journal of proteomics\| PubMed ID: 30016717	2018
Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis. Bioorganic chemistry\| PubMed ID: 30212765	2018
Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis. Journal of molecular biology\| PubMed ID: 30292819	2018
Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer. Oncotarget\| PubMed ID: 30333908	2018
Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of . ACS infectious diseases\| PubMed ID: 31299146	2019
PML hyposumoylation is responsible for the resistance of pancreatic cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology\| PubMed ID: 31557059	2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation. Clinical epigenetics\| PubMed ID: 31606046	2019
Clustering as a Means To Control Nitrate Respiration Efficiency and Toxicity in Escherichia coli. mBio\| PubMed ID: 31641084	2019
Integrative proteomic and phosphoproteomic profiling of prostate cell lines. PloS one\| PubMed ID: 31675377	2019